Helix BioPharma Corp. (HBP.TO)
0.82
-0.16
(-16.33%)
CAD |
TSX |
Oct 23, 16:00
Helix BioPharma Market Cap : 62.63M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 62.63M |
| October 22, 2026 | 74.85M |
| October 21, 2026 | 74.85M |
| October 20, 2026 | 74.85M |
| October 19, 2026 | 74.85M |
| October 16, 2026 | 74.85M |
| October 15, 2026 | 69.50M |
| October 14, 2026 | 70.27M |
| October 13, 2026 | 73.32M |
| October 09, 2026 | 70.27M |
| October 08, 2026 | 70.27M |
| October 07, 2026 | 68.74M |
| October 06, 2026 | 70.27M |
| October 05, 2026 | 74.85M |
| October 02, 2026 | 74.85M |
| October 01, 2026 | 72.56M |
| September 30, 2026 | 69.50M |
| September 29, 2026 | 80.96M |
| September 28, 2026 | 87.07M |
| September 25, 2026 | 78.67M |
| September 24, 2026 | 84.02M |
| September 23, 2026 | 84.02M |
| September 22, 2026 | 89.36M |
| September 21, 2026 | 110.75M |
| September 18, 2026 | 110.75M |
| Date | Value |
|---|---|
| September 17, 2026 | 106.93M |
| September 16, 2026 | 106.93M |
| September 15, 2026 | 105.40M |
| September 14, 2026 | 106.93M |
| September 11, 2026 | 110.75M |
| September 10, 2026 | 116.09M |
| September 09, 2026 | 124.50M |
| September 08, 2026 | 137.48M |
| September 04, 2026 | 137.48M |
| September 03, 2026 | 141.30M |
| September 02, 2026 | 156.58M |
| September 01, 2026 | 136.72M |
| August 31, 2026 | 147.41M |
| August 28, 2026 | 145.12M |
| August 27, 2026 | 145.12M |
| August 26, 2026 | 148.17M |
| August 25, 2026 | 151.99M |
| August 24, 2026 | 153.52M |
| August 21, 2026 | 150.46M |
| August 20, 2026 | 152.76M |
| August 19, 2026 | 152.76M |
| August 18, 2026 | 152.76M |
| August 17, 2026 | 154.28M |
| August 14, 2026 | 142.83M |
| August 13, 2026 | 137.48M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Microbix Biosystems, Inc. | 43.83M |
| Sernova Biotherapeutics, Inc. | 41.54M |
| Hemostemix, Inc. | 11.27M |
| Medicenna Therapeutics Corp. | 39.23M |
| Spectral Medical, Inc. | 293.55M |
Market Cap Related Metrics
| Price to Book Value | 4.264 |
| Price | 0.82 |
| Earnings Yield | -5.37% |